Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22482940

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2012 Apr 21
First author
Castaigne S

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 Apr 21;379(9825):1468-9. doi: 10.1016/S0140-6736(12)60534-0.
    note
    Source null
    related pmid
    22482941
    relationship
    Comment in
  2. citation
    Lancet. 2018 Mar 3;391(10123):838. doi: 10.1016/S0140-6736(17)32105-0.
    note
    Source null
    related pmid
    29429595
    relationship
    Erratum in

Authors and identifiers

  1. name
    Castaigne S
    type
    Author
  2. name
    Pautas C
    type
    Author
  3. name
    Terré C
    type
    Author
  4. name
    Raffoux E
    type
    Author
  5. name
    Bordessoule D
    type
    Author
  6. name
    Bastie JN
    type
    Author
  7. name
    Legrand O
    type
    Author
  8. name
    Thomas X
    type
    Author
  9. name
    Turlure P
    type
    Author
  10. name
    Reman O
    type
    Author
  11. name
    de Revel T
    type
    Author
  12. name
    Gastaud L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Castaigne S
    type
    Author
  2. name
    Pautas C
    type
    Author
  3. name
    Terré C
    type
    Author
  4. name
    Raffoux E
    type
    Author
  5. name
    Bordessoule D
    type
    Author
  6. name
    Bastie JN
    type
    Author
  7. name
    Legrand O
    type
    Author
  8. name
    Thomas X
    type
    Author
  9. name
    Turlure P
    type
    Author
  10. name
    Reman O
    type
    Author
  11. name
    de Revel T
    type
    Author
  12. name
    Gastaud L
    type
    Author
bibliography ids
  1. nci-bib-404e4b3d7dbe8dd674d399f9
book metadata
content sha256
9f057719ad19b322eb8849f145ada7357d5721133553c873414ed78c68adc08c
document type
citation
dois
  1. 10.1016/S0140-6736(12)60485-1
electronic publication date
display
2012 Apr 5
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22482940
immutable id
pubmed:22482940@9f057719ad19b322eb8849f145ada7357d5721133553c873414ed78c68adc08c
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9825
name
Lancet (London, England)
nlm unique id
2985213R
pages
1508-16
volume
379
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 Apr 21;379(9825):1468-9. doi: 10.1016/S0140-6736(12)60534-0.
    note
    Source null
    related pmid
    22482941
    relationship
    Comment in
  2. citation
    Lancet. 2018 Mar 3;391(10123):838. doi: 10.1016/S0140-6736(17)32105-0.
    note
    Source null
    related pmid
    29429595
    relationship
    Erratum in
outcomes validated
false
pmid
22482940
provenance
batch id
c95be1d0b8cf19942816
provider
NCBI PubMed ESummary
record sha256
0f5435ea27c83653b611d833d0aba6b213d20111fd42156f8217993a428020d2
response sha256
a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
retrieved at
2026-09-09T23:46:47.691937+00:00
publication date
display
2012 Apr 21
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22482940/
title
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.

Preserved source evidence · Not medical advice